Advertisement

Search Results

Advertisement



Article Topics

Your search for Paul Kluetz, MD, and Martha Donoghue, MD matches 1 pages

Showing 1 - 1


issues in oncology

FDA Programs to Expedite Drug and Biologic Product Development

With the advent of Breakthrough Therapy designation, there are now four FDA programs to expedite the development of promising new agents: Fast Track, Breakthrough Therapy, Priority Review, and Accelerated Approval (Table 1). These programs complement one another and serve a common goal: to speed...

Advertisement

Advertisement



Advertisement